Effects of genistein and 2-methoxyestradiol on matrix metalloproteinases and their inhibitors secreted by Ehrlich ascites tumor cells

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1691-1694

  Fajardo, Ignacio ^a   Díez, Emma ^a   Rodríguez Nieto, Salvador ^a   Rodríguez Caso, Carlos ^a   Quesada, Ana R ^a   Sánchez Jiménez, Francisca ^a   Medina, Miguel Ángel ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

2 methoxyestradiol; Ehrlich cells; Genistein; Matrix metalloproteinases; Tissue inhibitor of matrix metalloproteinase

Indexed keywords

2 METHOXYESTRADIOL; ANGIOGENESIS INHIBITOR; GELATINASE A; GELATINASE B; GENISTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EHRLICH ASCITES TUMOR CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR MODEL;

ANIMALS; ASCITIC FLUID; CARCINOMA, EHRLICH TUMOR; CELL ADHESION; ENZYME INHIBITORS; ESTRADIOL; GENISTEIN; MATRIX METALLOPROTEINASES; MICE; PERITONEAL CAVITY; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0343090393     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
2. Dvorak HF, Nagy JA and Dvorak AM: Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 3: 77-85, 1991.
3. Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, Sioussat TM and Dvorak HF: Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 55: 360-368, 1995.
4. Nagy JA, Meyers MS, Masse EM, Herzberg KT and Dvorak HF: Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity. Cancer Res 55: 369-375, 1995.
5. Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM and Dvorak HF: Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res 55: 376-385, 1995.
6. Danø K, Andreasen PA, Grohndahl-Hansen J, Krestensen PJ, Niclsen LS and Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44: 139-266, 1985.
7. Liotta LA, Tryggvason K, Garbisa S, Hart IR, Foltz CM and Shaflie S: Metastatic potential correlates with enzymatic degradation of basement matrix collagen. Nature 284: 67-69, 1980.
8. Edmonard H and Grimaud JA: Matrix metalloproteinases. A review. Cell Mol Biol 36: 131-153, 1990.
9. Blasi F, Riccio A and Sebatio G: Human plasminogen activators: genes and protein structure. In: Blasi F (ed.) Human Genes and Diseases. Wiley, London, 377-414, 1986.
10. Andreasen PA, Georg B, Lund LR, Riccio A and Stacey SN: Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 68: 1-19, 1990.
11. Montesano R: Regulation of angiogenesis in vitro. Eur J Clin Invest 22: 504-515, 1992.
12. Schweigerer L, Christeleit K, Fleischmann G, Adlercreutz H, Wahala K, Hase T, Schwab M, Ludwig R and Fotsis T: Identification in human urine of a natural growth inhibitor of cells derived from solid pediatric tumors, Eur J Clin Invest 22: 260-264, 1992.
13. Fotsis T, Pepper M, Adlercreutz H, Fleischman, Hase T, Montesano R and Schweigerer L: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90: 2690-2694, 1993.
14. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nauroth PP and Schweigerer L: The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppreses tumour growth. Nature 368: 237-239, 1994.
15. Barnes S, Peterson G, Grubbs C and Setchell K: Potential role of dietary isoflavones in the prevention of cancer. In: Jacobs MM (ed.) Diet and Cancer: Markeres, Prevention and Treatment, Plenum, New York, 135-147, 1994.
16. Peterson G and Barnes S: Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differentiation 7: 1345-1351, 1996.
17. Garcia de Veas R, Schweigerer L and Medina MA: Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein. Eur J Cancer 34: 1736-1740, 1998.
18. Fajardo I, Quesada AR, Núñez de Castro I, Sánchez-Jiménez F and Medina MA: A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation. British J Cancer 80: 17-24, 1999.
19. Mossman T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
20. Pérez Rodriguez J, Sánchez-Jiménez F, Márquez FJ, Medina MA, Quesada AR and Núñez de Castro I: Malate-citrate cycle during glycolysis and glutaminolysis in Ehrlich ascites tumor cells. Biochimie 69: 469-474, 1987.
21. Márquez J, Sánchez-Jiménez F, Medina MA, Quesada AR and Núñez de Castro I: Nitrogen metabolism in tumor bearing mice. Arch Biochem Biophys 268: 667-675.
22. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M and Fuami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592-5595, 1987.